查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636712

2030 年单细胞分析转录组学市场预测：按产品类型、样本类型、工作流程阶段、技术、应用、最终用户和地区进行的全球分析

Single-Cell Analysis Transcriptomics Market Forecasts to 2030 - Global Analysis By Product, Analysis Type, Sample Type, Workflow Stage, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球单细胞分析转录组学市场预计在 2024 年达到 52.2 亿美元，到 2030 年将达到 160.1 亿美元，预测期内的复合年增长率为 20.5%。

单细胞转录组学是在单一细胞层级研究基因表现的前沿方法。这使得发现稀有细胞类型、细胞状态和分化等动态过程成为可能。各种技术使研究人员能够揭示有关发展、疾病机制和治疗目标的关键见解，为在单细胞分辨率下理解复杂的生物系统提供了前所未有的精确度。

美国癌症协会报告称，预计 2022 年美国将诊断出 190 万例新癌症病例，609,360 人死于癌症。

精准医疗需求不断成长

由于精准医疗专注于根据个别基因和分子特征制定个人化治疗方案，单细胞转录组学可以提供有关细胞异质性的关键见解，使研究人员能够了解疾病在细胞层面的表现方式。透过分析单细胞分辨率的基因表现，该技术有助于识别稀有细胞群、疾病生物标记和治疗靶点，以推进个人化治疗策略。肿瘤学、免疫学和罕见疾病领域的应用将确保更准确的诊断和治疗方案，从而增加医疗保健领域的需求。

资料分析的复杂性

单细胞转录组学资料分析的复杂性源于产生的大量资料，其解释需要先进的计算方法。细胞间的变异、脱落事件和噪音进一步使这个过程变得复杂。研究人员必须处理不同样本的资料整合、丛集和解释，这需要高级生物资讯学专业知识。对专门工具和强大的计算基础设施的需求增加了挑战。这些复杂性减缓了单细胞技术的广泛应用。

增加基因组学研究的投资

政府、私人实体和创业投资的不断增加的资金正在支持成本更低、更准确和可扩展的单细胞技术的开发。这项投资将使人们更深入了解基因表现、分化和疾病机制等复杂的生物过程。这将加速单细胞转录组学在癌症研究、免疫学和再生医学等不同领域的应用。此外，它将促进研究机构、生物技术公司和受託研究机构之间的合作，以进一步促进市场成长和应用。

道德问题

单细胞转录组学中的伦理问题主要源自于人体组织的使用，特别是在涉及遗传疾病、癌症和生殖医学等敏感情况的研究中。同意、隐私以及基因资料的潜在滥用等议题都已列入监管议程。此外，个人和可识别资料的处理存在道德复杂性，引发了对资料安全的担忧。这些因素可能会增加获得伦理核准所需的成本和时间、限制研究范围以及阻碍研究机构和行业相关人员之间的合作，从而减缓市场成长。

COVID-19 的影响

COVID-19 大流行加速了单细胞转录组学的采用，并推动了对在细胞层面上研究病毒-宿主相互作用和免疫反应的先进工具的需求。然而，市场面临的挑战包括供应链中断、研究计划延迟以及非新冠研究资金减少。儘管存在这些挫折，但这场疫情凸显了单细胞技术在应对全球健康挑战中可以发挥的重要作用，并刺激了市场的长期成长。

预计癌症基因组学将成为预测期内最大的细分市场。

预计癌症基因组学领域将在整个预测期内占据最大的市场占有率。单细胞转录组学透过提供对肿瘤异质性、克隆进化和肿瘤微环境的无与伦比的洞察，彻底改变了癌症基因组学。这种方法将识别罕见的癌细胞亚群，追踪疾病进展，并揭示抗治疗性机制。这种精确度将提高我们对癌症生物学的理解，并为个人化、标靶治疗介入铺平道路。

预计预测期内，受託研究机构（CRO）部门将以最高的复合年增长率成长。

预计委外研发机构（CRO）部门在预测期内将呈现最高的复合年增长率。 CRO 越来越多地利用单细胞转录组学来支持药物发现和开发。该技术将有助于识别分子标靶、了解疾病机制并在细胞层面评估药物疗效。透过提供生物资讯学专业知识和先进的平台，CRO 可确保高品质的结果并加速精准医疗的发展。

比最大的地区

由于基因组学研究的投资不断增加、政府对医疗保健进步的倡议以及精准医疗的日益普及，预计亚太地区将在预测期内占据最大的市场占有率。中国、日本和印度等国家在扩大研究基础设施和产学研合作方面处于该地区领先地位。此外，慢性病和癌症的高发性也推动了对先进转录组学工具的需求。该地区拥有巨大的技术进步和市场扩张潜力。

复合年增长率最高的地区：

由于强大的研究基础设施、先进基因组技术的广泛采用以及政府对精准医疗和基因组学的大力资助，预计北美将在预测期内实现最高的复合年增长率。在主要企业和学术机构的支持下，美国在癌症、免疫学和神经生物学领域开展了广泛的研究活动，在该地区处于领先地位。加拿大也正在加大对生物技术的投资，并且正在成为重要的贡献者。先进的生物资讯学工具和熟练的专业人员进一步推动了市场的成长。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业进行基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球单细胞分析转录组学市场（按产品）

  • 装置
    • 定序仪
    • 流式细胞仪
    • 显微镜
  • 耗材
    • 试剂和套件
    • 微孔盘
    • 珠

6. 全球单细胞分析转录组学市场（依分析类型）

  • 基因表现
  • 表观基因
  • 代谢体学
  • 蛋白质体学
  • 其他分析类型

7. 全球单细胞分析转录组学市场（依样本类型）

  • 人类细胞
  • 动物细胞
  • 微生物细胞
  • 植物细胞
  • 其他样品类型

8. 全球单细胞分析转录组学市场（依工作流程阶段划分）

  • 样品製备
  • 样品分离
  • 资料分析
  • 资料解释
  • 其他工作流程阶段

9. 全球单细胞分析转录组学市场（按技术）

  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 微阵列
  • 单细胞 RNA定序（scRNA-Seq）
  • 原位杂交（ISH）
  • 其他技术

第 10 章。

  • 癌症基因体学
  • 神经病学
  • 免疫学
  • 干细胞研究
  • 疾病诊断
  • 个人化医疗
  • 生物标记发现
  • 其他应用

第 11 章。

  • 学术和研究机构
  • 製药和生物技术公司
  • 医院和诊断实验室
  • 合约研究组织 (CRO)
  • 其他最终用户

第 12 章。

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十三章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十四章 公司概况

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Becton, Dickinson and Company
  • QIAGEN NV
  • Illumina Inc.
  • PerkinElmer Inc.
  • Agilent Technologies
  • Pacific Biosciences
  • Sartorius AG
  • Promega Corporation
  • Luminex Corporation
  • Merck KGaA
  • Zephyrus Biosciences
  • Miltenyi Biotec
  • Oxford Nanopore Technologies
  • Novogene Corporation
  • Fluidigm Corporation
  • Cell Signaling Technology Inc.
  • 10x Genomics
  • NanoString Technologies
Product Code: SMRC28353

According to Stratistics MRC, the Global Single-Cell Analysis Transcriptomics Market is accounted for $5.22 billion in 2024 and is expected to reach $16.01 billion by 2030 growing at a CAGR of 20.5% during the forecast period. Single-cell analysis transcriptomics is a cutting-edge approach to studying gene expression at the individual cell level. It enables the discovery of rare cell types, cell states, and dynamic processes such as differentiation. By using various technologies, researchers can uncover critical insights into development, disease mechanisms, and therapeutic targets, offering unprecedented precision in understanding complex biological systems at a single-cell resolution.

According to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S.

Market Dynamics:

Driver:

Rising demand for precision medicine

As precision medicine focuses on tailoring treatments based on individual genetic and molecular profiles, single-cell transcriptomics provides critical insights into cellular heterogeneity, enabling researchers to understand how diseases manifest at the cellular level. By analyzing gene expression at single-cell resolution, this technology helps identify rare cell populations, disease biomarkers, and therapeutic targets, advancing personalized treatment strategies. Its application in oncology, immunology, and rare diseases further fuels the market's expansion, ensuring more accurate diagnostics and treatment options, which boosts demand in the healthcare sector.

Restraint:

Complexity of data analysis

The complexity of data analysis in single-cell analysis transcriptomics arises from the large volume of data generated, which requires sophisticated computational methods to interpret. Variability between cells, dropout events, and noise further complicate the process. Researchers must handle data integration, clustering, and interpretation across diverse samples, demanding advanced bioinformatics expertise. The need for specialized tools and high-performance computing infrastructure adds to the challenge. This complexity thereby slowdowns widespread adoption of single-cell technologies

Opportunity:

Growing investments in genomics research

Increased funding from governments, private organizations, and venture capital firms supports the development of more affordable, precise, and scalable single-cell technologies. This investment enables better understanding of complex biological processes, such as gene expression, differentiation, and disease mechanisms. As a result, it accelerates the adoption of single-cell transcriptomics in diverse fields, including cancer research, immunology, and regenerative medicine. Moreover, it fosters collaborations between research institutions, biotechnology companies, and contract research organizations, further advancing the market's growth and application.

Threat:

Ethical concerns

Ethical concerns in single-cell analysis transcriptomics arise mainly from the use of human tissues, especially for research involving sensitive conditions like genetic diseases, cancer, and reproductive health. Issues like consent, privacy, and the potential for misuse of genetic data create regulatory challenges. The ethical complexity of handling personal and identifiable data also raises concerns about data security. These factors can slow market growth by increasing the costs and time required to obtain ethical approvals, limit the scope of research, and deter collaboration between institutions and industry players.

Covid-19 Impact

The covid-19 pandemic accelerated the adoption of single-cell analysis transcriptomics, driving demand for advanced tools to study viral-host interactions and immune responses at cellular resolution. However, the market faced challenges such as disrupted supply chains, delayed research projects, and reduced funding for non-covid studies. Despite these setbacks, the pandemic underscored the critical role of single-cell technologies in addressing global health challenges, fostering long-term market growth.

The cancer genomics segment is expected to be the largest during the forecast period

The cancer genomics segment is predicted to secure the largest market share throughout the forecast period. Single-cell analysis transcriptomics is revolutionizing cancer genomics by providing unparalleled insights into tumor heterogeneity, clonal evolution, and the tumor microenvironment. This approach identifies rare cancer cell subpopulations, tracks disease progression, and uncovers mechanisms of therapy resistance. This precision enhances understanding of cancer biology, paving the way for personalized and targeted therapeutic interventions.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

The contract research organizations (CROs) segment is anticipated to witness the highest CAGR during the forecast period. CROs are increasingly leveraging single-cell analysis transcriptomics to support drug discovery and development. This technology aids in identifying molecular targets, understanding disease mechanisms, and evaluating drug efficacy at a cellular resolution. By offering expertise in bioinformatics and advanced platforms, CROs ensure high-quality results, facilitating the development of precision medicines.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period fuelled by increasing investments in genomics research, government initiatives to advance healthcare, and the rising adoption of precision medicine. Countries like China, Japan, and India are leading the region with growing research infrastructure and collaborations between academia and industry. Additionally, the high prevalence of chronic diseases and cancer drives the demand for advanced transcriptomic tools. The region presents immense potential for technological advancements and market expansion.

Region with highest CAGR:

North America is expected to witness the highest CAGR over the forecast period driven by robust research infrastructure, high adoption of advanced genomic technologies, and strong government funding for precision medicine and genomics. The U.S. leads the region with extensive research activities in cancer, immunology, and neurobiology, supported by key players and academic institutions. Canada is also emerging as a significant contributor with growing investments in biotechnology. The presence of advanced bioinformatics tools and skilled professionals further accelerates market growth.

Key players in the market

Some of the key players profiled in the Single-Cell Analysis Transcriptomics Market include Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company, QIAGEN N.V., Illumina Inc., PerkinElmer Inc., Agilent Technologies, Pacific Biosciences, Sartorius AG, Promega Corporation, Luminex Corporation, Merck KGaA, Zephyrus Biosciences, Miltenyi Biotec, Oxford Nanopore Technologies, Novogene Corporation, Fluidigm Corporation, Cell Signaling Technology Inc., 10x Genomics and NanoString Technologies.

Key Developments:

In October 2024, Cell Signaling Technology (CST) has announced the launch of InTraSeq(TM) Single Cell Analysis Reagents, a reliable, efficient and convenient way to simultaneously detect and study intracellular proteins and the transcriptome in a single-cell experiment, while guaranteeing a robust RNA signal.

In June 2024, Bio-Rad Laboratories, Inc. launched the ddSEQTM Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research. Designed to be run on Bio-Rad's droplet-based single-cell isolation system, the ddSEQ Cell Isolator, the ddSEQ Single-Cell 3' RNA-Seq Kit delivers high-quality single-cell 3' RNA-Seq libraries in a fast, efficient, and affordable workflow, allowing researchers to easily conduct single-cell gene expression and regulation analyses.

Products Covered:

  • Instruments
  • Consumables

Analysis Types Covered:

  • Gene Expression Profiling
  • Epigenomics
  • Metabolomics
  • Proteomics
  • Other Analysis Types

Sample Types Covered:

  • Human Cells
  • Animal Cells
  • Microbial Cells
  • Plant Cells
  • Other Sample Types

Workflow Stages Covered:

  • Sample Preparation
  • Sample Isolation
  • Data Analysis
  • Data Interpretation
  • Other Workflow Stages

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • Single-Cell RNA Sequencing (scRNA-Seq)
  • In Situ Hybridization (ISH)
  • Other Technologies

Applications Covered:

  • Cancer Genomics
  • Neurology
  • Immunology
  • Stem Cell Research
  • Disease Diagnosis
  • Personalized Medicine
  • Biomarker Discovery
  • Other Applications

End Users Covered:

  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Single-Cell Analysis Transcriptomics Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Sequencers
    • 5.2.2 Flow Cytometers
    • 5.2.3 Microscopes
  • 5.3 Consumables
    • 5.3.1 Reagents & Kits
    • 5.3.2 Microplates
    • 5.3.3 Beads

6 Global Single-Cell Analysis Transcriptomics Market, By Analysis Type

  • 6.1 Introduction
  • 6.2 Gene Expression Profiling
  • 6.3 Epigenomics
  • 6.4 Metabolomics
  • 6.5 Proteomics
  • 6.6 Other Analysis Types

7 Global Single-Cell Analysis Transcriptomics Market, By Sample Type

  • 7.1 Introduction
  • 7.2 Human Cells
  • 7.3 Animal Cells
  • 7.4 Microbial Cells
  • 7.5 Plant Cells
  • 7.6 Other Sample Types

8 Global Single-Cell Analysis Transcriptomics Market, By Workflow Stage

  • 8.1 Introduction
  • 8.2 Sample Preparation
  • 8.3 Sample Isolation
  • 8.4 Data Analysis
  • 8.5 Data Interpretation
  • 8.6 Other Workflow Stages

9 Global Single-Cell Analysis Transcriptomics Market, By Technology

  • 9.1 Introduction
  • 9.2 Next-Generation Sequencing (NGS)
  • 9.3 Polymerase Chain Reaction (PCR)
  • 9.4 Microarrays
  • 9.5 Single-Cell RNA Sequencing (scRNA-Seq)
  • 9.6 In Situ Hybridization (ISH)
  • 9.7 Other Technologies

10 Global Single-Cell Analysis Transcriptomics Market, By Application

  • 10.1 Introduction
  • 10.2 Cancer Genomics
  • 10.3 Neurology
  • 10.4 Immunology
  • 10.5 Stem Cell Research
  • 10.6 Disease Diagnosis
  • 10.7 Personalized Medicine
  • 10.8 Biomarker Discovery
  • 10.9 Other Applications

11 Global Single-Cell Analysis Transcriptomics Market, By End User

  • 11.1 Introduction
  • 11.2 Academic & Research Institutions
  • 11.3 Pharmaceutical & Biotechnology Companies
  • 11.4 Hospitals & Diagnostic Laboratories
  • 11.5 Contract Research Organizations (CROs)
  • 11.6 Other End Users

12 Global Single-Cell Analysis Transcriptomics Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Thermo Fisher Scientific
  • 14.2 Bio-Rad Laboratories
  • 14.3 Becton, Dickinson and Company
  • 14.4 QIAGEN N.V.
  • 14.5 Illumina Inc.
  • 14.6 PerkinElmer Inc.
  • 14.7 Agilent Technologies
  • 14.8 Pacific Biosciences
  • 14.9 Sartorius AG
  • 14.10 Promega Corporation
  • 14.11 Luminex Corporation
  • 14.12 Merck KGaA
  • 14.13 Zephyrus Biosciences
  • 14.14 Miltenyi Biotec
  • 14.15 Oxford Nanopore Technologies
  • 14.16 Novogene Corporation
  • 14.17 Fluidigm Corporation
  • 14.18 Cell Signaling Technology Inc.
  • 14.19 10x Genomics
  • 14.20 NanoString Technologies

List of Tables

  • Table 1 Global Single-Cell Analysis Transcriptomics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Single-Cell Analysis Transcriptomics Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Single-Cell Analysis Transcriptomics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 4 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sequencers (2022-2030) ($MN)
  • Table 5 Global Single-Cell Analysis Transcriptomics Market Outlook, By Flow Cytometers (2022-2030) ($MN)
  • Table 6 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microscopes (2022-2030) ($MN)
  • Table 7 Global Single-Cell Analysis Transcriptomics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 8 Global Single-Cell Analysis Transcriptomics Market Outlook, By Reagents & Kits (2022-2030) ($MN)
  • Table 9 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microplates (2022-2030) ($MN)
  • Table 10 Global Single-Cell Analysis Transcriptomics Market Outlook, By Beads (2022-2030) ($MN)
  • Table 11 Global Single-Cell Analysis Transcriptomics Market Outlook, By Analysis Type (2022-2030) ($MN)
  • Table 12 Global Single-Cell Analysis Transcriptomics Market Outlook, By Gene Expression Profiling (2022-2030) ($MN)
  • Table 13 Global Single-Cell Analysis Transcriptomics Market Outlook, By Epigenomics (2022-2030) ($MN)
  • Table 14 Global Single-Cell Analysis Transcriptomics Market Outlook, By Metabolomics (2022-2030) ($MN)
  • Table 15 Global Single-Cell Analysis Transcriptomics Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 16 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Analysis Types (2022-2030) ($MN)
  • Table 17 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Type (2022-2030) ($MN)
  • Table 18 Global Single-Cell Analysis Transcriptomics Market Outlook, By Human Cells (2022-2030) ($MN)
  • Table 19 Global Single-Cell Analysis Transcriptomics Market Outlook, By Animal Cells (2022-2030) ($MN)
  • Table 20 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microbial Cells (2022-2030) ($MN)
  • Table 21 Global Single-Cell Analysis Transcriptomics Market Outlook, By Plant Cells (2022-2030) ($MN)
  • Table 22 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Sample Types (2022-2030) ($MN)
  • Table 23 Global Single-Cell Analysis Transcriptomics Market Outlook, By Workflow Stage (2022-2030) ($MN)
  • Table 24 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Preparation (2022-2030) ($MN)
  • Table 25 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Isolation (2022-2030) ($MN)
  • Table 26 Global Single-Cell Analysis Transcriptomics Market Outlook, By Data Analysis (2022-2030) ($MN)
  • Table 27 Global Single-Cell Analysis Transcriptomics Market Outlook, By Data Interpretation (2022-2030) ($MN)
  • Table 28 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Workflow Stages (2022-2030) ($MN)
  • Table 29 Global Single-Cell Analysis Transcriptomics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 30 Global Single-Cell Analysis Transcriptomics Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)
  • Table 31 Global Single-Cell Analysis Transcriptomics Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)
  • Table 32 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microarrays (2022-2030) ($MN)
  • Table 33 Global Single-Cell Analysis Transcriptomics Market Outlook, By Single-Cell RNA Sequencing (scRNA-Seq) (2022-2030) ($MN)
  • Table 34 Global Single-Cell Analysis Transcriptomics Market Outlook, By In Situ Hybridization (ISH) (2022-2030) ($MN)
  • Table 35 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 36 Global Single-Cell Analysis Transcriptomics Market Outlook, By Application (2022-2030) ($MN)
  • Table 37 Global Single-Cell Analysis Transcriptomics Market Outlook, By Cancer Genomics (2022-2030) ($MN)
  • Table 38 Global Single-Cell Analysis Transcriptomics Market Outlook, By Neurology (2022-2030) ($MN)
  • Table 39 Global Single-Cell Analysis Transcriptomics Market Outlook, By Immunology (2022-2030) ($MN)
  • Table 40 Global Single-Cell Analysis Transcriptomics Market Outlook, By Stem Cell Research (2022-2030) ($MN)
  • Table 41 Global Single-Cell Analysis Transcriptomics Market Outlook, By Disease Diagnosis (2022-2030) ($MN)
  • Table 42 Global Single-Cell Analysis Transcriptomics Market Outlook, By Personalized Medicine (2022-2030) ($MN)
  • Table 43 Global Single-Cell Analysis Transcriptomics Market Outlook, By Biomarker Discovery (2022-2030) ($MN)
  • Table 44 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 45 Global Single-Cell Analysis Transcriptomics Market Outlook, By End User (2022-2030) ($MN)
  • Table 46 Global Single-Cell Analysis Transcriptomics Market Outlook, By Academic & Research Institutions (2022-2030) ($MN)
  • Table 47 Global Single-Cell Analysis Transcriptomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2022-2030) ($MN)
  • Table 48 Global Single-Cell Analysis Transcriptomics Market Outlook, By Hospitals & Diagnostic Laboratories (2022-2030) ($MN)
  • Table 49 Global Single-Cell Analysis Transcriptomics Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 50 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.